Design-rules for stapled peptides with in vivo activity and their application to Mdm2/X antagonistsArun Chandramohan, Anthony W. Partridge, Tsz Ying Yuen et al.|Nature Communications|2024Cited by 40
MDM2/MDMX inhibition by Sulanemadlin synergizes with anti-Programmed Death 1 immunotherapy in wild-type p53 tumorsKatrine Ingelshed, Diana Spiegelberg|iScience|2024Cited by 14
The Novel Anti-cMet Antibody seeMet 12 Potentiates Sorafenib Therapy and Radiotherapy in a Colorectal Cancer ModelDiana Spiegelberg, Marika Nestor|Frontiers in Oncology|2020Cited by 6